Stockreport

Nektar Stock Surges On Rezpegaldesleukin Phase 2b Maintenance Data: What It Means [Seeking Alpha]

Nektar Therapeutics  (NKTR) 
Last nektar therapeutics earnings: 2/27 04:15 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.nektar.com/investor-relations
PDF NKTR's novel Treg agonist mechanism offers differentiated, flexible dosing and potential best-in-class safety versus established biologics like Dupixent. Despite stro [Read more]